Filing Details

Accession Number:
0001209191-17-037298
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-02 16:39:58
Reporting Period:
2017-06-01
Filing Date:
2017-06-02
Accepted Time:
2017-06-02 16:39:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
893949 Mednax Inc. MD Services-Hospitals (8060) 263667538
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1443082 A. David Clark 1301 Concord Terrace
Sunrise FL 33323
Pres. Mednax Natl Med Group No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-01 15,277 $0.00 35,302 No 4 A Direct
Common Stock Disposition 2017-06-01 10,202 $54.99 25,100 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance based criteria but will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.
  2. Sales made pursuant to Reporting Person's 10b5-1 trading plan.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in fifty-three (53) separate transactions with prices ranging from $54.16 to $55.39 for an average weighted sales price of $54.9932. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.